Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Bigg Boss Malayalam 6 Voting Results: Not Arjun, THIS Contestant Beats Jasmin To Get Highest Votes In Week 7 -
IPL 2024: RCB to Play 250th IPL Match Today - Records by Seasons, Win Percentage, Latest Stats So Far -
JPMorgan CEO Jamie Dimon Hails PM Modi's Economic Reforms, Urges US to Follow Suit; Details -
New Features Of The Ultraviolette F77 Mach 2: Uniting Performance, Safety, And Technology -
When Will Vaishakh Month 2024 Start? Vrats And Festivals That Will Fall This Month, Complete List! -
JEE Main Result 2024 Out, Telangana's 15 Toppers Shine, Check Statewise List of 56 Candidates with Perfect 100 -
Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary -
OPPO Find X7 Ultra Camera Deep-Dive: Pushing the Boundaries of Photography on a Smartphone
Dr Reddy launches 'Supanac' tablets
Hyderabad, Jan 16 (UNI) Dr Reddy's Laboratories has launched Supanac (Diclofenac Potassium 50 mg) tablets in India, increasing its offering in the Rs 2,700 crore Non-Steroidal Anti-Inflammatory Drug (NSAID) market.
The drug, with analgesic, anti-pyretic and anti-inflammatory properties licensed from Applied Pharma Research (APR) of Switzerland, is used for acute pain management, a release here said.
This patented product was developed by Dynamic Buffered Technology (DBT).
UNI
VA
DS
GM
1806
Comments
Story first published: Wednesday, January 16, 2008, 18:35 [IST]
